Free Trial
NASDAQ:POAI

Predictive Oncology (POAI) Stock Price, News & Analysis

Predictive Oncology logo
$7.44 -0.12 (-1.59%)
As of 11/4/2026

About Predictive Oncology Stock (NASDAQ:POAI)

Advanced

Key Stats

Today's Range
$7.26
▼
$7.87
50-Day Range
$7.44
▼
$12.99
52-Week Range
$0.71
▼
$16.54
Volume
152,001 shs
Average Volume
473,545 shs
Market Capitalization
$25.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Predictive Oncology Inc. (NASDAQ: POAI) is a biotechnology company focused on applying artificial intelligence, machine learning, and laboratory-based cancer research to drug discovery and precision oncology. The company uses tumor samples and related biological data to study how individual cancers may respond to potential treatments.

Its technology offerings have included AI-enabled platforms designed to analyze cancer data, identify potential drug candidates, and predict treatment responses. Predictive Oncology has also provided tumor profiling, drug-screening, biobanking, and contract research services to pharmaceutical, biotechnology, and academic customers.

The company has developed its operations through acquisitions and affiliated businesses, including Helomics, a precision oncology company specializing in patient-derived tumor models and drug-response testing. Predictive Oncology is headquartered in the United States and serves customers in the life sciences and healthcare research sectors. The company was formerly known as Skyline Medical before adopting the Predictive Oncology name as its business shifted toward artificial intelligence and cancer research.

AI Generated. May Contain Errors.

Receive POAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Predictive Oncology and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

POAI Stock News Headlines

What Elon Musk's Cybercab Reveal Could Mean for Investors
Jeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He points to a new AI project tied to Musk's Cybercab reveal. Brown says Musk has opened major investment windows before, with PayPal, Tesla, and SpaceX marking milestones in tech history. He believes a fourth may open by October 30.tc pixel
Predictive Oncology Regains Nasdaq Compliance
See More Headlines

POAI Stock Analysis - Frequently Asked Questions

Predictive Oncology's stock was trading at $7.15 at the beginning of the year. Since then, POAI shares have increased by 4.1% and is now trading at $7.44.

Predictive Oncology Inc. (NASDAQ:POAI) issued its quarterly earnings data on Friday, November, 14th. The medical instruments supplier reported ($4.52) earnings per share for the quarter, missing the consensus estimate of ($1.35) by $3.17. The medical instruments supplier had revenue of $3.62 thousand for the quarter, compared to the consensus estimate of $1.50 million. Predictive Oncology had a negative net margin of 5,065.23% and a negative trailing twelve-month return on equity of 732.73%.
Read the conference call transcript
.

Predictive Oncology's stock reverse split on the morning of Tuesday, September 30th 2025.The 1-15 reverse split was announced on Thursday, September 25th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Monday, September 29th 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of POAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Predictive Oncology investors own include FuelCell Energy (FCEL), Tesla (TSLA), NVIDIA (NVDA), Plug Power (PLUG), AMC Entertainment (AMC), Bionano Genomics (BNGO) and Lithium Americas (LAC).

Company Calendar

Last Earnings
11/14/2025
Today
11/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
IT Services
Sub-Industry
Internet Services & Infrastructure
Current Symbol
NASDAQ:POAI
CIK
1446159
Fax
N/A
Employees
30
Year Founded
2002

Profitability

EPS (Trailing Twelve Months)
($13.50)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.66 million
Net Margins
-5,065.23%
Pretax Margin
-5,082.34%
Return on Equity
-732.73%
Return on Assets
-235.55%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.01
Quick Ratio
0.01

Sales & Book Value

Annual Sales
$1.66 million
Price / Sales
15.17
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.46) per share
Price / Book
-16.17

Miscellaneous

Outstanding Shares
3,394,000
Free Float
3,353,000
Market Cap
$25.25 million
Optionable
Not Optionable
Beta
1.35

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

This page (NASDAQ:POAI) was last updated on 11/4/2026 by MarketBeat.com Staff.
From Our Partners